세계의 줄기세포 어세이 시장 : 규모, 점유율, 성장 분석, 제품 유형별, 분석 유형별, 용도별, 최종 사용자별, 지역별 산업 예측(2024-2031년)
Stem Cell Assay Market Size, Share, Growth Analysis, By Product Type (Instruments, Flow Cytometers), By Assay Type (Cell Viability & Toxicity Assays, Cell Identification Assays), By Application, By End-User, By Region - Industry Forecast 2024-2031
상품코드:1619080
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
줄기세포 어세이 세계 시장 규모는 2022년에 19억 달러로 평가되었고, 2023년 22억 4,000만 달러에서 2031년에는 82억 4,000만 달러로 성장하며 예측 기간(2024-2031년) CAGR는 17.7%로 나타날 전망입니다.
줄기세포 어세이 시장은 입수 곤란한 세포종의 안정적인 이용가능성과 생리학적 관련 모델의 개발에 의해 큰 성장을 이루고 있습니다. 법과 제네릭 의약품의 발견을 촉진하고 있습니다. 의학 연구 및 창약에서 줄기 세포 어세이에 대한 수요 증가는 제약 부문의 확대와 함께 역동적 인 시장을 계속 진행하고 있습니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 상황
특허 분석
사례 연구
줄기세포 어세이 시장 규모 : 제품 유형별 및 CAGR(2024-2031년)
시장 개요
기기
플로우 사이토미터
미세 전극 어레이
세포 이미징 시스템
소모품
시약 및 키트
마이크로플레이트
분석 키트
줄기세포 어세이 시장 규모 : 어세이 유형별 및 CAGR(2024-2031년)
시장 개요
세포 생존율 및 독성 분석
Mtt 분석
트리판 블루 제외 시험
세포 식별 시험
면역세포화학
플로우 사이토메트리
세포 증식 시험
Brdu 분석
EdU 분석
세포분화시험
알칼리성 포스파타제 시험
면역형광 어세이
기타
아폽토시스 시험
이동시험
줄기세포 어세이 시장 규모 : 용도별 및 CAGR(2024-2031년)
시장 개요
재생 의료 및 치료법의 개발
신경학
종양학
심장혈관
의약품의 발견과 개발
독성시험
유효성 시험
임상조사
질병 모델
줄기세포의 특성 평가
줄기세포 어세이 시장 규모 : 최종 사용자별 및 CAGR(2024-2031년)
시장 개요
제약·바이오테크놀러지 기업
의약품 개발
품질관리
학술연구기관
기초조사
트랜스레이셔널 조사
계약연구기관(Cros)
전임상 연구
임상시험
줄기세포 어세이 시장 규모 및 CAGR(2024-2031년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2021-2023년)
주요 기업 프로파일
Thermo Fisher Scientific Inc.(USA)
Merck KGaA(Germany)
Danaher Corporation(USA)
Becton, Dickinson and Company(USA)
Bio-Rad Laboratories, Inc.(USA)
Promega Corporation(USA)
Bio-Techne Corporation(USA)
FUJIFILM Holdings Corporation(Japan)
Charles River Laboratories(USA)
HemoGenix, Inc.(USA)
Lonza Group(Switzerland)
Takara Bio Inc.(Japan)
Creative Bioarray(USA)
AAT Bioquest, Inc.(USA)
BPS Bioscience, Inc.(USA)
Enzo Biochem, Inc.(USA)
PromoCell GmbH(Germany)
Biotium, Inc.(USA)
Geno Technology, Inc.(USA)
결론과 권장사항
JHS
영문 목차
영문목차
Global Stem Cell Assay Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.24 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 17.7% during the forecast period (2024-2031).
The stem cell assay market is experiencing significant growth driven by the consistent availability of hard-to-source cell types and the development of physiologically relevant models. Recent advancements in medical infrastructure and technology innovations have transformed treatment protocols and facilitated the discovery of novel therapies and generic drugs. Cell-based assays are increasingly employed to evaluate key parameters such as cell viability, cytotoxicity, and senescence, particularly within high-throughput screening environments. Furthermore, heightened investment and intensified research initiatives in stem cell assays have fostered the emergence of safer treatment options. The rising demand for stem cell-based assays in medical research and drug discovery, coupled with the expansion of the pharmaceutical sector, continues to propel this dynamic market forward.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Stem Cell Assay Market Segmental Analysis
Global Stem Cell Assay Market is segmented by product type, assay type, application, end-user and region. Based on product type, the market is segmented into instruments and consumables. Based on assay type, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell differentiation assays and others. Based on application, the market is segmented into regenerative medicine & therapy development, drug discovery & development and clinical research. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Stem Cell Assay Market
The global stem cell assay market is fundamentally influenced by a rising health consciousness among the population and ongoing population growth. While the COVID-19 pandemic posed significant challenges for various sectors, the stem cell assay market demonstrated resilience, with key players maintaining their product offerings despite the downturn. The continuous advancements in stem cell assays not only address the complexities of global demand but also enhance the quality of care provided to patients. As health awareness escalates, the demand for innovative stem cell assays is likely to grow, positioning the market for sustained development in the future.
Restraints in the Global Stem Cell Assay Market
The Global Stem Cell Assay market faces several restraints, one of the most significant being the high cost of raw materials. This economic challenge affects various industrial sectors, hindering their ability to maintain sustainable production operations. The elevated expenses associated with sourcing essential materials can lead to increased pricing for finished products, ultimately impacting market growth and accessibility. Companies in the stem cell research and therapeutic fields may struggle to balance the need for quality inputs with budget constraints, potentially limiting innovation and the advancement of stem cell technologies. Therefore, addressing this financial barrier is crucial for the market's overall development.
Market Trends of the Global Stem Cell Assay Market
The Global Stem Cell Assay market is witnessing a notable upward trend, driven by the rising emphasis on personalized medicine and regenerative therapies. This greater focus has catalyzed the demand for stem cell assays, essential for streamlining drug discovery and development processes. Furthermore, significant technological advancements and the integration of automation have markedly improved the efficiency and accuracy of these assays, resulting in superior research outcomes and cost-effectiveness. As pharmaceutical companies and research institutions increasingly prioritize these innovative approaches, the stem cell assay market is poised for substantial growth, reflecting broader shifts toward precision and tailored healthcare solutions.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies
Global Stem Cell Assay Market Size by Product Type & CAGR (2024-2031)
Market Overview
Instruments
Flow Cytometers
Microelectrode Arrays
Cell Imaging Systems
Consumables
Reagents & Kits
Microplates
Assay Kits
Global Stem Cell Assay Market Size by Assay Type & CAGR (2024-2031)
Market Overview
Cell Viability & Toxicity Assays
Mtt Assay
Trypan Blue Exclusion Assay
Cell Identification Assays
Immunocytochemistry
Flow Cytometry
Cell Proliferation Assays
Brdu Assay
Edu Assay
Cell Differentiation Assays
Alkaline Phosphatase Assay
Immunofluorescence Assay
Others
Apoptosis Assays
Migration Assays
Global Stem Cell Assay Market Size by Application & CAGR (2024-2031)
Market Overview
Regenerative Medicine & Therapy Development
Neurology
Oncology
Cardiovascular
Drug Discovery & Development
Toxicology Testing
Efficacy Testing
Clinical Research
Disease Modeling
Stem Cell Characterization
Global Stem Cell Assay Market Size by End-User & CAGR (2024-2031)
Market Overview
Pharmaceutical & Biotechnology Companies
Drug Development
Quality Control
Academic & Research Institutes
Basic Research
Translational Research
Contract Research Organizations (Cros)
Preclinical Studies
Clinical Trials
Global Stem Cell Assay Market Size & CAGR (2024-2031)
North America (Product Type, Assay Type, Application, End-User)
USA
Canada
Europe (Product Type, Assay Type, Application, End-User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Assay Type, Application, End-User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Assay Type, Application, End-User)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Assay Type, Application, End-User)
